Abeona Therapeutics Inc. buy Cantor Fitzgerald
Start price
24.08.23
/
50%
€3.64
Target price
24.08.24
€35.10
Performance (%)
-15.98%
Price
26.04.24
€3.06
Summary
This prediction is currently active. The prediction for Abeona Therapeutics Inc. disappoints with a performance of -15.98%. This prediction currently runs until 24.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abeona Therapeutics Inc. | -56.901% | -56.901% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Abeona Therapeutics Inc. diskutieren
Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Abeona Therapeutics Inc.
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.68
23.04.24
23.04.24
€33.73
23.04.25
23.04.25
-16.85%
26.04.24
26.04.24
